Efficacy, safety and patient acceptability of fentanyl pectin nasal spray compared with immediate-release morphine sulphate tablets in the treatment of breakthrough cancer pain: a multicentre, double-blind, double-dummy, multiple-crossover study

被引：5
|
作者：
Fallon, M. [1 ]
Gatti, A. [6 ]
Davies, A. [2 ]
Lux, E. A. [5 ]
Kumar, K. [4 ]
Galvez, R. [3 ]
机构：
[1] Western Gen Hosp, Palliat Care Team, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Royal Marsden NHS Fdn Trust, Surrey, England
[3] Unidad Dolor Hosp Virgen Nieves, Unidad Pain & Palliat Care, Granada, Spain
[4] Meenakshi Mission Hosp, Dept Radiat & Clin Oncol, Madurai, Tamil Nadu, India
[5] St Marien Hosp, Abt Schmerztherapie, Lunen, Germany
[6] AFA Emergenza Urgenza Terapia Intens & Terapia Do, Azienda Policlin Tor Vergata, Rome, Italy
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(09)72064-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 20 条
  • [1] EFFICACY OF FENTANYL PECTIN NASAL SPRAY COMPARED WITH IMMEDIATE-RELEASE MORPHINE SULFATE IN BREAKTHROUGH CANCER PAIN EVALUATED IN A RANDOMIZED DOUBLE-BLIND, DOUBLE-DUMMY CROSSOVER STUDY
    Fallon, Marie
    Smith, Carrie
    Reale, Carlo
    Lynch, Louise
    Sitte, Thomas
    Galvez, Rafael
    ONCOLOGY NURSING FORUM, 2011, 38 (02) : E170 - E170
  • [2] Efficacy and safety of fentanyl pectin nasal spray versus immediate-release morphine sulphate tablets in the treatment of breakthrough cancer pain
    Fallon, M. T.
    Davies, A.
    Gatti, A.
    Lux, E. A.
    Watling, M.
    Galvez, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate in Breakthrough Cancer Pain
    Davies, Andrew
    Sitte, Thomas
    Elsner, Frank
    Reale, Carlo
    Espinosa, Jose
    Brooks, David
    Fallon, Marie
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 41 (02) : 358 - 366
  • [4] A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain
    Portenoy, Russell K.
    Burton, Allen W.
    Gabrail, Nashat
    Taylor, Donald
    PAIN, 2010, 151 (03) : 617 - 624
  • [5] A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain
    Bruera, E
    Sloan, P
    Mount, B
    Scott, J
    SuarezAlmazor, M
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1713 - 1717
  • [6] EFFICACY, TOLERABILITY, AND SPEED OF ONSET OF FENTANYL PECTIN NASAL SPRAY IN THE TREATMENT OF BREAKTHROUGH CANCER PAIN: A MULTICENTER, PLACEBO- CONTROLLED, DOUBLE-BLIND, TWO-PHASE CROSSOVER STUDY
    Smith, Carrie
    Gabrail, Nashat
    Burton, Allen
    Reyes, Evangeline
    Nguyen, An
    Taylor, Donald
    ONCOLOGY NURSING FORUM, 2011, 38 (02) : E174 - E174
  • [7] Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study
    Rauck, Richard
    Reynolds, Lowell
    Geach, Jonathan
    Bull, Janet
    Stearns, Lisa
    Scherlis, Morris
    Parikh, Neha
    Dillaha, Larry
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 859 - 870
  • [8] The efficacy, tolerability, and speed of onset of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP): A multicenter, placebo-controlled, double-blind, two-phase crossover study
    Gabrail, N. Y.
    Burton, A. W.
    Reyes, E.
    Nguyen, A.
    Taylor, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients
    Inoue, Satoshi
    Saito, Yoji
    Tsuneto, Satoru
    Aruga, Etsuko
    Takahashi, Hiroshi
    Uemori, Mitsutoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 542 - 547
  • [10] A Randomized, Double-Blind, Placebo-Controlled Study of Fentanyl Buccal Tablets for Breakthrough Pain: Efficacy and Safety in Japanese Cancer Patients
    Kosugi, Toshifumi
    Hamada, Sasagu
    Takigawa, Chizuko
    Shinozaki, Katsunori
    Kunikane, Hiroshi
    Goto, Fumio
    Tanda, Shigeru
    Shima, Yasuo
    Yomiya, Kinomi
    Matoba, Motohiro
    Adachi, Isamu
    Yoshimoto, Tetsusuke
    Eguchi, Kenji
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (06) : 990 - 1000
12